These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2343804)

  • 1. Purification of 45 KDa estramustine binding protein (EMBP) and preparation of its antibody.
    Yuasa H; Yamanaka H; Imai K; Mashimo T; Kohno H
    Hinyokika Kiyo; 1990 Feb; 36(2):121-5. PubMed ID: 2343804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
    Shiina H; Ishibe T; Usui T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of estramustine-binding protein and production of monoclonal antibodies to its different components.
    Björk P; Donn F; Glad C; Sundblad G; Vestberg M; Kalland T
    Prostate; 1995 Aug; 27(2):70-83. PubMed ID: 7638085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
    Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
    Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma.
    Björk P; Borg A; Fernö M; Nilsson S
    Anticancer Res; 1991; 11(3):1173-82. PubMed ID: 1888147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of monoclonal antibody against the C1 component of rat estramustine-binding protein: immunohistochemical study of rat prostate.
    Tamura Y; Yuasa H; Suzuki T; Yamanaka H; Suzuki K
    Histochem Cell Biol; 1995 Dec; 104(6):429-33. PubMed ID: 8777728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and analysis of an 80-kDa carcinoembryonic antigen-binding protein from Kupffer cells.
    Gangopadhyay A; Lazure DA; Kelly TM; Thomas P
    Arch Biochem Biophys; 1996 Apr; 328(1):151-7. PubMed ID: 8638924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new scalable purification procedure for prostatic secretory protein (PSP94) from human seminal plasma.
    Baijal-Gupta M; Fraser JE; Clarke MW; Xuan JW; Finkelman MA
    Protein Expr Purif; 1996 Dec; 8(4):483-8. PubMed ID: 8954897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate.
    Bichler KH; Flüchter SH; Nelde HJ; Björk P; Müntzing J
    Prostate; 1989; 14(1):13-25. PubMed ID: 2467273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H; Igawa M; Ishibe T
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
    Björk PA; Flüchter SH; Nelde HJ
    Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
    Björk P; Isaacs JT; Hartley-Asp B
    Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of 26- and 30-kDa rat liver proteins immunoreactive to anti-sterol carrier protein-2 antibodies.
    Pu L; Foxworth WB; Kier AB; Annan RS; Carr SA; Edmondson R; Russell D; Wood WG; Schroeder F
    Protein Expr Purif; 1998 Aug; 13(3):337-48. PubMed ID: 9693058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
    Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
    Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoaffinity purification of juvenile hormone-binding protein from Galleria mellonella hemolymph.
    Wieczorek E; Parkitna JM; Szkudlarek J; Ozyhar A; Kochman M
    Acta Biochim Pol; 1996; 43(4):603-10. PubMed ID: 9104496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and measurement of HDL3-binding proteins in human peripheral blood mononuclear cells.
    Hidaka H; Tozuka M; Yamauchi K; Ohta H; Nakayama J; Katsuyama T
    Ann Clin Lab Sci; 2003; 33(3):271-8. PubMed ID: 12956441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, properties and identification of a serum DNA binding protein (64DP) and its microheterogeneity.
    Tsuda M; Ohkubo T; Kamiguchi H; Suzuki K; Nakasaki H; Mitomi T; Katsunuma T
    Tokai J Exp Clin Med; 1982 Mar; 7(2):201-11. PubMed ID: 6808710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
    Shiina H; Sumi H; Ishibe T; Usui T
    Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.